Optical biometry-based axial length alterations after intravitreal dexamethasone implant

Basit Öğe Kaydı
dc.authoridOzal, Sadik Altan/0000-0003-0078-1049
dc.authorwosidOzal, Sadik Altan/B-5123-2019
dc.contributor.authorOzal, Sadik Altan
dc.contributor.authorKupeli, Ayca
dc.contributor.authorOzal, Ece
dc.contributor.authorGurlu, Vuslat
dc.date.accessioned2024-06-12T10:54:06Z
dc.date.available2024-06-12T10:54:06Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose: To investigate changes in axial length after intravitreal dexamethasone implantation in patients with macular edema. Methods: We performed a prospective comparative study of 46 patients with unilateral macular edema, due to diabetic retinopathy, retinal vein occlusion, and non-infectious uveitis, who underwent dexamethasone implantation. The fellow eyes of the patients were considered the control group. The central macular thickness was measured by spectral-domain optical coherence tomography, and axial length was measured by IOLMaster 700 optical coherence biometry. We compared axial length and central macular thickness values within the groups. Results: In the study group, the baseline central macular thickness was 460.19 +/- 128.64 mu m, significantly decreasing to 324.00 +/- 79.84 mu m after dexamethasone implantation (p=0.000). No significant change in central macular thickness measurements was seen in the control group (p=0.244). In the study group, the baseline axial length was 23.16 +/- 0.68 mm, significantly increasing to 23.22 +/- 0.65 mm after dexamethasone implantation (p=0.039). However, the control group exhibited no significant change in axial length (p=0.123). Conclusions: In addition to significantly reducing central macular thickness measurements, intravitreal dexamethasone implantation also significantly changes optical biometry-based axial length measurements.en_US
dc.identifier.doi10.5935/0004-2749.20190040
dc.identifier.endpage199en_US
dc.identifier.issn0004-2749
dc.identifier.issn1678-2925
dc.identifier.issue3en_US
dc.identifier.pmid30810616en_US
dc.identifier.scopus2-s2.0-85066285394en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage195en_US
dc.identifier.urihttps://doi.org/10.5935/0004-2749.20190040
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18919
dc.identifier.volume82en_US
dc.identifier.wosWOS:000468123600006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherConsel Brasil Oftalmologiaen_US
dc.relation.ispartofArquivos Brasileiros De Oftalmologiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAxial Length, Eyeen_US
dc.subjectDexamethasone/Administration & Dosageen_US
dc.subjectIntravitreal Injections, Drug Implantsen_US
dc.subjectMacular Edemaen_US
dc.subjectChamber Depth Measurementsen_US
dc.subjectDiabetic Macular Edemaen_US
dc.subjectControlled-Trialen_US
dc.subjectCataracten_US
dc.subjectSeverityen_US
dc.subjectAccuracyen_US
dc.subjectTherapyen_US
dc.titleOptical biometry-based axial length alterations after intravitreal dexamethasone implanten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu